Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VELCADE in multiple myeloma with renal failure
NCT01084837Phase 2Completed
- Sponsor
- Fundación PETHEMA
- Start
- Mar 2010
- Primary completion
- Sep 2012
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of bortezomib in multiple myeloma (MM), sponsored by Fundación PETHEMA. Started Mar 2010; status: completed.
02
Drugs
bortezomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01084837.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01084837.